University of Patras
Μελέτη της έκφρασης δεικτών του κυτταρικού κύκλου καθώς και αγγειογενετικών παραγόντων σε ασθενείς με ηπατοκυτταρικό καρκίνωμα, οι οποίοι υπέστησαν μερική ηπατεκτομή για θεραπευτικούς λόγους: συσχέτιση με την μετεγχειρητική επιβίωση των ασθενών και τους κλασικούς προγνωστικούς δείκτες της νόσου
Abstract
dc:descriptionHCC is a common, yet highly aggressive neoplasm with low survival rates. As a result, the better understanding of the biology of this disease and the finding of predictive biomarkers and new therapeutic targets is of particular scientific interest. The HCC usually develops in patients with hepatitis and cirrhosis, due to chronic inflammation and damage of the hepatocytes. On a molecular level, DNA damage and genomic instability are common features of the disease. Similar to any cancer, malignant cells in HCC acquire specific characteristics, hallmarks, that allows them to sustain proliferative signaling, evade growth suppressors, resist cell death, enable replicative immortality, induce angiogenesis, and activate invasion and metastasis. Genomic instability, characterized by accumulation of mutations, is one of the major mechanisms behind the development and progression of cancer. Alongside, DNA damage due to replicative stress and the DNA damage responses are considered cornerstones of oncogenesis. Cell cycle checkpoints play a very important role in the control of proliferation and in the maintenance of genomic integrity. An important control mechanism of the cell cycle is the licensing of DNA replication. The DNA replication licensing factors control DNA replication, preventing replicative stress and genomic instability. In addition, the IPP complex (ILK-parvin-PINCH), mainly on focal adhesions, by mediating the signalling between cells and extracellular matrix (ECM) and growth factors, controls proliferation, invasion, metastasis and angiogenesis.The aim of the present study, was to evaluate the expression of cell cycle and angiogenic markers in patients with hepatocellular carcinoma. We analysed formalin-fixed paraffin-embedded biopsy specimens from a total of 111 patients who underwent hepatectomy or curative resection for HCC. In those samples, we evaluated the role of DNA replication licensing factors Cdt1 and Mcm7, DDR factors p-H2AX, phospho-ATM/ATR and p53, angiogenetic factor VEGF-A, vascular density marker CD31 and the IPP complex (ΙLK, β-parvin και PINCH). Moreover, we evaluated the prognostic significance through correlations with the clinicopathological characteristics of HCC and the survival of the patients. Our study demonstrated that Cdt1 is overexpressed in HCC, correlates with tumor grade and TNM stage and is a predictor of poor survival in patients with HCC (p=0.049). In addition, we showed that Mcm7 is also overexpressed in HCC and correlates with DDR, although, no correlations were found with the clinicopathological characteristics of HCC and the survival of the patients. Interestingly, the DDR factors p-H2AX, phospho-ATM/ATR and p53 were overexpressed in HCC and were correlated with the expression of licensing factors Cdt1 and Mcm7. Furthermore, we found that ILK is overexpressed in HCC and correlates with the studied licensing, DDR and angiogenic factors and that β-parvin and PINCH are also overexpressed in HCC. Finally, we identified that growth factor VEGF-A is overexpressed in HCC and correlates with poor survival in patients with HBV and that vascular density factor CD31 is correlated with invasion in HCC.Further studies are needed to validate our results, to identify the link between DNA licensing deregulation and genomic instability in HCC, to delineate the role of the IPP complex and to explore any possible clinical applications.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karavias, Dimitrios
- Καραβίας, Δημήτριος
Subjects
dc:subject × 17- Ηπατοκυτταρικός καρκίνος
- Βλάβες DNA
- Αγγειογένεση
- Αδειοδότηση της αντιγραφής του DNA
- Αντιγραφή του DNA
- Hepatocellular carcinoma
- DNA damage response
- Angiogenesis
- DNA licensing
- DNA repair
- DNA replication
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Κλινική Ιατρική
- Medical and Health Sciences
- Basic Medicine
- Clinical Medicine
Rights
dc:rights- Statement dc:rights
-
- BY_NC_SA
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40158